mtor-dependent synapse formation underlies rapid antidepressant effects nmda antagonists 
rapid antidepressant response ketamine administration treatment-resistant depressed patients suggests possible new approach treating mood disorders compared weeks months required standard medications however mechanisms underlying action ketamine [a glutamate n-methyl-d-aspartic acid nmda receptor antagonist] identified observed ketamine rapidly activated mammalian target rapamycin mtor pathway leading increased synaptic signaling proteins increased number function new spine synapses prefrontal cortex rats moreover blockade mtor signaling completely blocked ketamine induction synaptogenesis behavioral responses models depression results demonstrate effects ketamine opposite synaptic deficits result exposure stress contribute fast antidepressant actions ketamine 
